Physical activity in long-term survivors of germ-cell cancer

Editorial

S Sleijfer et al. Eur J Cancer. 2003 Jun.

. 2003 Jun;39(9):1191-3.

doi: 10.1016/s0959-8049(03)00269-7.

No abstract available

Comment on

The level of physical activity in long-term survivors of testicular cancer.
Thorsen L, Nystad W, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD. Thorsen L, et al. Eur J Cancer. 2003 Jun;39(9):1216-21. doi: 10.1016/s0959-8049(03)00151-5. Eur J Cancer. 2003. PMID: 12763208

Survival from testicular cancer in England and Wales up to 2001.
Huddart RA. Huddart RA. Br J Cancer. 2008 Sep 23;99 Suppl 1(Suppl 1):S83-5. doi: 10.1038/sj.bjc.6604598. Br J Cancer. 2008. PMID: 18813271 Free PMC article. No abstract available.
[The role of cytostatic polychemotherapy in the treatment of germinal testicular tumors].
Hegenscheid M, Möhner M, Schulze H. Hegenscheid M, et al. Z Urol Nephrol. 1990 Jun;83(6):297-302. Z Urol Nephrol. 1990. PMID: 2171247 German. No abstract available.
A multivariate analysis of prognostic factors in disseminated non-seminomatous testicular cancer.
Stoter G, Sylvester R, Sleijfer DT, ten Bokkel Huinink WW, Kaye SB, Jones WG, van Oosterom AT, Vendrik CP, Spaander P, de Pauw M. Stoter G, et al. Prog Clin Biol Res. 1988;269:381-93. Prog Clin Biol Res. 1988. PMID: 2455909 Clinical Trial. No abstract available.
Overview: treatment of local regional disease.
Donohue JP. Donohue JP. Prog Clin Biol Res. 1990;350:283-93. Prog Clin Biol Res. 1990. PMID: 2166958 Review. No abstract available.
Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer.
Kantoff PW, Garnick MB. Kantoff PW, et al. J Clin Oncol. 1988 Aug;6(8):1216-9. doi: 10.1200/JCO.1988.6.8.1216. J Clin Oncol. 1988. PMID: 2842462 Review. No abstract available.